<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02723396</url>
  </required_header>
  <id_info>
    <org_study_id>EOC.NSI.LS.15.3.I</org_study_id>
    <nct_id>NCT02723396</nct_id>
  </id_info>
  <brief_title>Sleep, Awake &amp; Move - Part I</brief_title>
  <acronym>SA&amp;M-I</acronym>
  <official_title>Sleep &amp; Move. Systematic Characterisation of Sleep Benefit in Parkinson's Disease. An Observational, Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Neurocenter of Southern Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Parkinson Schweiz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ente Ospedaliero Cantonale, Bellinzona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Penn State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Neurocenter of Southern Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sleep benefit (SB) is a prominent spontaneous, apparently unpredictable, transitory
      improvement in motor function reported by around 50% of patients affected by Parkinson's
      Disease (PD) after sleep and before taking their first dose of dopaminergic medications. This
      study aims at systematically characterizing SB in PD patients in an ecological setting and to
      explore the relationships between nocturnal and diurnal sleep and subjective and objective
      measures of motor function. A better understanding of this phenomenon is mandatory for future
      research on this topic.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The &quot;Sleep &amp; Move&quot; study is the first part of the Sleep, Awake &amp; Move project. In this
      observational study we plan to systematically investigate SB and the day-to-day variation in
      this phenomenon in PD patients by a prospective, repeated assessment for 14 days of both
      subjective and objective measures of motor function and sleep at patients' home, by an
      Android app developed ad hoc.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Objective prospective and repeated assessment of motor function</measure>
    <time_frame>from day 0 to day 15</time_frame>
    <description>Finger tapping test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective prospective and repeated assessment of motor function</measure>
    <time_frame>from day 0 to day 15</time_frame>
    <description>Visual analogue scale (VAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Objective prospective assessment of sleep and wakefulness</measure>
    <time_frame>from day 0 to day 15</time_frame>
    <description>Wrist actigraphy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective prospective assessment of sleep and wakefulness</measure>
    <time_frame>from day 0 to day 15</time_frame>
    <description>Electronic sleep diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective prospective assessment of sleepiness</measure>
    <time_frame>from day 0 to day 15</time_frame>
    <description>Stanford Sleepiness Scale (SSS)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Idiopathic Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Sleep &amp; Move</arm_group_label>
    <description>Prospective observation of a cohort of consecutive patients with idiopathic PD in an ecological setting</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Outpatients with mild to moderate idiopathic Parkinson's Disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnostic criteria of idiopathic Parkinson's disease (UKPDBB)

          -  Mild to moderate disease (Hoehn &amp; Yahr score ≥ 1 and &lt; 3)

          -  Mentally and physically capable to give informed consent

          -  Stable antiparkinsonian and psychotropic therapy for the last 30 days

        Exclusion Criteria:

          -  Atypical parkinsonian syndrome

          -  Cognitive impairment (MMSE ≥ 26)

          -  Deep brain stimulation

          -  History of cerebro-vascular disease, epilepsy, or other disabling neurological
             diseases

          -  Psychiatric disorders, excepting mild depression (BDI score &lt;14)

          -  Alcohol abuse

          -  Other clinically significant severe concomitant disease states

          -  Inability to follow the procedures of the study (e.g. due to language problems,
             psychological disorders, etc.)

          -  Participation in another study with investigational drug within the 60 days preceding
             and during the present project.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pietro Luca Ratti, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sleep and Epilepsy center Department of Neurology, Neurocenter of Southern Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pietro Luca Ratti, MD, PhD</last_name>
    <phone>+41(0)918116849</phone>
    <email>PietroLuca.Ratti@eoc.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ninfa Amato, PhD</last_name>
    <phone>+41(0)795553120</phone>
    <email>Ninfa.Amato@eoc.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sleep and Epilepsy center Department of Neurology, Neurocenter of Southern Switzerland</name>
      <address>
        <city>Lugano</city>
        <zip>6903</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pietro Luca Ratti, MD, PhD</last_name>
      <phone>+41(0)918116849</phone>
      <email>PietroLuca.Ratti@eoc.ch</email>
    </contact>
    <contact_backup>
      <last_name>Ninfa Amato, PhD</last_name>
      <phone>+41(0)795553120</phone>
      <email>Ninfa.Amato@eoc.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Pietro Luca Ratti, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alain Kälin-Lang, Pr, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ninfa Amato, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Silvia Miano, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandra Hackethal, Med. Stud.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>De Cock VC, Vidailhet M, Leu S, Texeira A, Apartis E, Elbaz A, Roze E, Willer JC, Derenne JP, Agid Y, Arnulf I. Restoration of normal motor control in Parkinson's disease during REM sleep. Brain. 2007 Feb;130(Pt 2):450-6.</citation>
    <PMID>17235126</PMID>
  </reference>
  <reference>
    <citation>Stefani A, Galati S, Peppe A, Bassi A, Pierantozzi M, Hainsworth AH, Bernardi G, Orlacchio A, Stanzione P, Mazzone P. Spontaneous sleep modulates the firing pattern of parkinsonian subthalamic nucleus. Exp Brain Res. 2006 Jan;168(1-2):277-80. Epub 2005 Nov 18.</citation>
    <PMID>16328297</PMID>
  </reference>
  <reference>
    <citation>Urrestarazu E, Iriarte J, Alegre M, Clavero P, Rodríguez-Oroz MC, Guridi J, Obeso JA, Artieda J. Beta activity in the subthalamic nucleus during sleep in patients with Parkinson's disease. Mov Disord. 2009 Jan 30;24(2):254-60. doi: 10.1002/mds.22351.</citation>
    <PMID>18951542</PMID>
  </reference>
  <reference>
    <citation>van Gilst MM, Bloem BR, Overeem S. &quot;Sleep benefit&quot; in Parkinson's disease: a systematic review. Parkinsonism Relat Disord. 2013 Jul;19(7):654-9. doi: 10.1016/j.parkreldis.2013.03.014. Epub 2013 Apr 21. Review.</citation>
    <PMID>23615667</PMID>
  </reference>
  <reference>
    <citation>Merello M, Hughes A, Colosimo C, Hoffman M, Starkstein S, Leiguarda R. Sleep benefit in Parkinson's disease. Mov Disord. 1997 Jul;12(4):506-8.</citation>
    <PMID>9251067</PMID>
  </reference>
  <reference>
    <citation>Currie LJ, Bennett JP Jr, Harrison MB, Trugman JM, Wooten GF. Clinical correlates of sleep benefit in Parkinson's disease. Neurology. 1997 Apr;48(4):1115-7.</citation>
    <PMID>9109914</PMID>
  </reference>
  <reference>
    <citation>Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord. 1999 Nov;14(6):922-7.</citation>
    <PMID>10584665</PMID>
  </reference>
  <reference>
    <citation>Bateman DE, Levett K, Marsden CD. Sleep benefit in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999 Sep;67(3):384-5.</citation>
    <PMID>10449564</PMID>
  </reference>
  <reference>
    <citation>Sherif E, Valko PO, Overeem S, Baumann CR. Sleep benefit in Parkinson's disease is associated with short sleep times. Parkinsonism Relat Disord. 2014 Jan;20(1):116-8. doi: 10.1016/j.parkreldis.2013.09.005. Epub 2013 Sep 12.</citation>
    <PMID>24084381</PMID>
  </reference>
  <reference>
    <citation>Högl BE, Gómez-Arévalo G, García S, Scipioni O, Rubio M, Blanco M, Gershanik OS. A clinical, pharmacologic, and polysomnographic study of sleep benefit in Parkinson's disease. Neurology. 1998 May;50(5):1332-9.</citation>
    <PMID>9595983</PMID>
  </reference>
  <reference>
    <citation>Högl B, Peralta C, Wetter TC, Gershanik O, Trenkwalder C. Effect of sleep deprivation on motor performance in patients with Parkinson's disease. Mov Disord. 2001 Jul;16(4):616-21.</citation>
    <PMID>11481684</PMID>
  </reference>
  <reference>
    <citation>Högl B, Gershanik O. Sleep benefit in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2000 Jun;68(6):798-9.</citation>
    <PMID>10877630</PMID>
  </reference>
  <reference>
    <citation>Factor SA, Weiner WJ. 'Sleep benefit' in Parkinson's disease. Neurology. 1998 May;50(5):1514-5.</citation>
    <PMID>9596032</PMID>
  </reference>
  <reference>
    <citation>Noyce AJ, Nagy A, Acharya S, Hadavi S, Bestwick JP, Fearnley J, Lees AJ, Giovannoni G. Bradykinesia-akinesia incoordination test: validating an online keyboard test of upper limb function. PLoS One. 2014 Apr 29;9(4):e96260. doi: 10.1371/journal.pone.0096260. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e105488.</citation>
    <PMID>24781810</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2016</study_first_submitted>
  <study_first_submitted_qc>March 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2016</study_first_posted>
  <last_update_submitted>March 23, 2016</last_update_submitted>
  <last_update_submitted_qc>March 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Neurocenter of Southern Switzerland</investigator_affiliation>
    <investigator_full_name>Pietro Luca Ratti</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Parkinson's disease</keyword>
  <keyword>Sleep Benefit</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

